Résistances/sensibilisations aux anti-CD20 (rituximab) dans les lymphomes diffus à grandes cellules B (DLBCL)

Hafidha Bentayeb(Université de Limoges)

HAL (Le Centre pour la Communication Scientifique Directe)

December 15, 2016

Cited by 1

Related Papers

Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects

|Journal of Experimental & Clinical Cancer Research|2019|29